palladium has been researched along with Acute Promyelocytic Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doi, H; Ishii, H; Koyama, H; Sumi, K; Suzuki, M; Takashima-Hirano, M; Watanabe, C | 1 |
Aldinucci, D; Cattaruzza, L; Colombatti, A; Fregona, D; Giovagnini, L; Lorenzon, D | 1 |
2 other study(ies) available for palladium and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Synthesis of (11)C-labeled retinoic acid, [(11)C]ATRA, via an alkenylboron precursor by Pd(0)-mediated rapid C-[(11)C]methylation.
Topics: Alkenes; Antineoplastic Agents; Boron Compounds; Carbon Isotopes; Catalysis; Contrast Media; Humans; Leukemia, Promyelocytic, Acute; Methylation; Palladium; Positron-Emission Tomography; Tretinoin | 2014 |
Antiproliferative and apoptotic effects of two new Pd(II) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Proliferation; Colony-Forming Units Assay; Cytoskeletal Proteins; Granulocyte Precursor Cells; Hematopoietic Stem Cells; HL-60 Cells; Humans; K562 Cells; Leukemia, Promyelocytic, Acute; Organometallic Compounds; Palladium; Proto-Oncogene Proteins c-bcl-2; Thiocarbamates | 2008 |